2-(Pyridin-2-ylmethylene)-N-(4'-tolyl)hydrazinecarbothioamide

ID: ALA4788932

Chembl Id: CHEMBL4788932

PubChem CID: 9687518

Max Phase: Preclinical

Molecular Formula: C14H14N4S

Molecular Weight: 270.36

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=S)N/N=C/c2ccccn2)cc1

Standard InChI:  InChI=1S/C14H14N4S/c1-11-5-7-12(8-6-11)17-14(19)18-16-10-13-4-2-3-9-15-13/h2-10H,1H3,(H2,17,18,19)/b16-10+

Standard InChI Key:  SUMXLQKGNVWFFU-MHWRWJLKSA-N

Associated Targets(Human)

MES-SA (905 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MES-SA/Dx5 (643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB 3-1 (1143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB-V1 (202 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HFF (3142 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 270.36Molecular Weight (Monoisotopic): 270.0939AlogP: 2.71#Rotatable Bonds: 3
Polar Surface Area: 49.31Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.35CX Basic pKa: 3.05CX LogP: 3.88CX LogD: 3.88
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.51Np Likeness Score: -2.46

References

1. Pape VF,Tóth S,Füredi A,Szebényi K,Lovrics A,Szabó P,Wiese M,Szakács G.  (2016)  Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance.,  117  [PMID:27161177] [10.1016/j.ejmech.2016.03.078]

Source